GBS vaccine study for healthy pregnant women and their babies
Treatments studied
This study tests a vaccine against Group B Streptococcus (GBS) during pregnancy to see if it can protect newborns from infection. Healthy pregnant women with a single baby can join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a healthy pregnant woman up to 49 years old.
- Your pregnancy is between 24 and 36 weeks along when you get the vaccine.
- You are having only one baby (no twins or triplets) and your pregnancy is low risk.
- You have had a negative HIV, syphilis, and hepatitis B test during this pregnancy.
- You agree to have your baby participate in the study and sign consent forms.
- You do not have a body mass index (BMI) over 40 before pregnancy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new vaccine to protect infants from pneumococcal disease (a serious bacterial infection). Researchers want to see how well the vaccine works and how safe it is in healthy babies aged 2–6 months.
This study is preparing for future trials of a vaccine for Group B Strep (GBS) in pregnant women. It includes different parts: watching pregnant women and their babies, surveying GBS infections, and understanding how communities feel about vaccines.
This study tests blood samples from women who received a Group B Streptococcus (GBS) vaccine during pregnancy to ensure the vaccine is working safely and correctly. Researchers want to check your immune response and confirm the vaccine quality.
This early-phase study looks at whether swabbing a mother’s vagina during a planned C-section (“vaginal seeding”) can help shape a newborn’s early respiratory and gut microbes. The goal is to see if this approach is safe and may influence early-life breathing health.
This study is a registry that collects information about the health and outcomes of babies and children who had a serious Group B Strep infection around birth. It aims to better understand the long-term effects and improve care for families impacted by this infection.
This study tests an approved RSV vaccine given to pregnant women. The goal is to see if it safely protects their babies from severe RSV lung infections during the first months of life.
Hear when a new Healthy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.